1.Development of slit-lamp microscope and its applications in optics.
Chinese Journal of Medical Instrumentation 2013;37(6):437-440
This paper mainly introduces the origin and development of the slit-lamp microscope, the basic structure, working principle and test methods, focuses on diffuse illumination, direct focal illumination, indirect illumination, retro illumination, zone of specular reflection and slit-lamp filter used in the optical inspection, to provide the reference for clinical general optometry practitioners and using slit-lamp microscope widely and standardized.
Lighting
;
instrumentation
;
Ophthalmology
;
instrumentation
2.Development of Slit-lamp Microscope and Its Applications in Optics
Chinese Journal of Medical Instrumentation 2013;(6):437-440
This paper mainly introduces the origin and development of the slit-lamp microscope,the basic structure, working principle and test methods, focuses on diffuse il umination, direct focal il umination, indirect il umination, retro il umination, zone of specular reflection and slit-lamp filter used in the optical inspection, to provide the reference for clinical general optometry practitioners and using slit-lamp microscope widely and standardized .
3.Research progress of radiolabeled bombesin drugs targeting GRPR in the diagnosis and treatment of prostate cancer
Haohui SONG ; Mengxin XU ; Xuqian MA ; Jie CAI ; Chao HE ; Binglin LIU ; Qi SU ; Zhibo LIU
Chinese Journal of Nuclear Medicine and Molecular Imaging 2024;44(12):764-768
Prostate cancer is the most common cancer among men and the fifth leading cause of cancer-related death among men worldwide. Gastrin-releasing peptide receptor (GRPR) is an important complementary target of prostate specific membrane antigen (PSMA) and a key target for prostate cancer diagnosis and treatment. Radionuclide labeled bombesin (BBN) analogues can accurately target overexpressed GRPR in tumor cells, thus providing early diagnosis and treatment of prostate cancer. In this review, we focus on the studies of 99Tc m, 111In, 68Ga, 64Cu, 18F, and 177Lu nuclide-labeled BBN analogues for diagnosis and peptide receptor radionuclide therapy.